As for the actions of TRIM47 in cancer pathogenesis and progression, a study recommends that TRIM47 joins in the modulation of ubiquitination-mediated degradation of oncogene products or tumor suppressors (Qian et al. 2022). This evidence concerns the gene TRIM47 and neoplasm.